Mankind Pharma Interview : Jobs in QA, QC, Production
4 August 2026

Mankind Pharma Interview : Jobs in QA, QC, Production

HPLC & GC operation Empower Software Wet Lab Analysis UV IR SOR LOD AIT KF BD FTIR PSD SA etc. Automated instrument operation. Mankind Pharma Interview, M.Pharm, B.Pharm, M.Sc, B.Sc
4 August 2026
Openings in Quality Assurance and Quality Control at IPCA Labs
B.Pharm | M.Pharm | B.Sc | BA | ITI | D.Pharma B.Com | M.Com, Ipca Labs
4 August 2026
Pharma and Chemistry Jobs in API and Formulation Plants at Cohance Lifesciences
Liquid filling, Packing, Compression, Granulation, Capsule Filling, Coating & Encapsulation
4 August 2026
Accenture looking for Life Science Regulatory Svs Analyst
In this role you are required to do analysis and solving of lower-complexity problems. Your day to day interaction is with peers within Accenture before updating supervisors.
4 August 2026
Work as Quality & Regulatory Affairs Manager at Baxter
Establish strong relationship with country regulatory authorities to facilitate technical and strategic discussions related to product. Baxter
4 August 2026
Drug Safety Associate Require at Accenture
You will be provided detailed to moderate level of instruction on daily work tasks and detailed instruction on new assignments
4 August 2026
Wipro Limited Hiring First Line Manager
Conduct briefings before every shift to drive focus on key metrices and debrief at the end of the shift to drive focus of the team on quality and adherence to contract compliance processes
4 August 2026
Apply Online for Associate Medical Writer at Thermo Fisher Scientific
Assists with researching, writing, and editing routine documents including Informed consent forms, Lay summaries, and other patient centric documents.
4 August 2026
IQVIA looking for Clinical Research Associate
Administer protocol and related study training to assigned sites and establish regular lines of communication with sites to manage ongoing project expectations and issues.
4 August 2026
Amgen Reports Material Cybersecurity Incident After Unauthorized Access to Cloud Data

Amgen Inc. has disclosed a material cybersecurity incident after identifying unauthorized activity involving data stored in cloud environments hosted by third-party service providers. The company revealed the incident in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (SEC).

According to the filing, Amgen detected the unauthorized activity in July 2026 and immediately activated its cybersecurity incident response plan. The company implemented containment measures and engaged independent cybersecurity forensic experts to investigate the breach.